Fujifilm’s Tender Offer for Toyama Chemical Begins (Part 1 Of 2)
This article was originally published in PharmAsia News
Executive Summary
TOKYO - Fujifilm Holding's tender offer for Japanese pharma Toyama Chemical started as scheduled on Feb. 19 and will last for one month. In a move that took many in the business industry by surprise, the top global photographic and imaging company declared its intent to move into the pharmaceutical business in a joint announcement with Toyama Chemical and Taisho Pharmaceutical, the top over-the-counter drug company in Japan and major shareholder of Toyama Chemical
You may also be interested in...
Fujifilm’s Tender Offer For Toyama Chemical Begins (Part 2 Of 2)
[Editor's Note: This is the second part of a two-part series. Part one covered the specifics of the offer.]
Fujifilm’s Tender Offer For Toyama Chemical Begins (Part 2 Of 2)
[Editor's Note: This is the second part of a two-part series. Part one covered the specifics of the offer.]
Analysis: Film-Maker Fujifilm To Enter Japan Drug Business with Toyama Chemical Acquisition
Fujifilm Holdings' bid to buy Toyama Chemical signals a move by companies with technologies beneficial to drug making to enter the pharmaceutical market. Ajinomoto, in the seasoning and food business, relies on fermentation technologies for its amino acid-based drugs, and Toray Industries applies biotechnology and nanotechnology to help develop drugs with long-lasting effects. Japan Pharmaceutical Manufacturers Association President Hatsuo Aoki said his industry expects to see an increase in mergers and acquisitions centered on certain technologies rather than company size. (Click here for more - a subscription may be required
Need a specific report? 1000+ reports available
Buy Reports